Clinical Trial Update: Drug Therapy in Lupus Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a drug therapy for lupus nephropathy in nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• Not disclosed

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Nephrotic Syndrome, Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED